ArticleTranslational oncology2026

A RIPK2 activity signature in prostate cancer: Modulation by RIPK2 inhibition and clinical association.

Ahmed M Elgehama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.